Tag: Histotripsy
First patient treated with HistoSonics Edison histotripsy system
HistoSonics, developer of a non-invasive platform and sonic beam therapy called histotripsy, has announced the treatment of the first patient in its pivotal #HOPE4KIDNEY...
HistoSonics receives FDA clearance for Edison histotripsy system
HistoSonics, the manufacturer of the Edison System and novel histotripsy therapy platforms, has announced the marketing authorisation of its “breakthrough” platform via the...
#HOPE4LIVER trial demonstrates safety and efficacy of histotripsy for liver tumours
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 annual meeting (9–13 September, Copenhagen, Denmark) played host to another FIRST@CIRSE session, which saw...
HistoSonics announces first kidney tumour treatment using histotripsy
HistoSonics has announced the first kidney patient has been treated using its histotripsy platform. The procedure was performed at the Leeds Teaching Hospitals NHS...
Interventional News’ top 10 most popular stories of February 2023
Interventional News’ most popular stories for the month of February included news from the Pan Arab Interventional Radiology Society annual meeting (PAIRS; 11–14 February,...
Histotripsy: New technology making waves in IO
Mina S Makary, assistant professor at the Division of Vascular and Interventional Radiology/Department of Radiology at the Ohio State University Wexner Medical Center (Columbus,...
HistoSonics receives FDA breakthrough device designation for novel sonic beam therapy
HistoSonics has revealed that the US Food and Drug Administration (FDA) has granted the company breakthrough device designation for its new histotripsy targeted liver...
Why histotripsy may be the next leap forward in ablative therapy
Histotripsy, which was invented at the University of Michigan, uses pulsed sound waves to destroy tissue. It is a non-invasive and non-thermal mechanism that...
Early clinical results suggest novel ablation modality may stimulate an abscopal...
Investigators report a 100% technical success rate in creating their planned ablation volume and no major device-related complications in the first-in-human clinical cases using...
